These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 30772178
41. Surgery in patients with congenital factor VII deficiency - a single center study. Szczepanik A, Wiszniewski A, Oses-Szczepanik A, Dąbrowski W, Pielaciński K, Misiak A. Pol Przegl Chir; 2018 May 22; 90(5):1-5. PubMed ID: 30426948 [Abstract] [Full Text] [Related]
42. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study. Hoffmann T, Assmann A, Dierksen A, Roussel E, Ullrich S, Lichtenberg A, Albert A, Sixt S. J Thorac Cardiovasc Surg; 2018 Oct 22; 156(4):1564-1573.e8. PubMed ID: 29884487 [Abstract] [Full Text] [Related]
43. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Aldouri M. Pathophysiol Haemost Thromb; 2002 Oct 22; 32 Suppl 1():41-6. PubMed ID: 12214147 [Abstract] [Full Text] [Related]
44. Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Alfirevic A, Duncan A, You J, Lober C, Soltesz E. Ann Thorac Surg; 2014 Aug 22; 98(2):618-24. PubMed ID: 24968771 [Abstract] [Full Text] [Related]
45. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. Guzzetta NA, Russell IA, Williams GD. Anesth Analg; 2012 Aug 22; 115(2):364-78. PubMed ID: 22652310 [Abstract] [Full Text] [Related]
46. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients. Faraoni D, Guindi A, Ankola AA, Resheidat A, Binsalamah Z, Teruya J, Savorgnan F, Vener DF. J Cardiothorac Vasc Anesth; 2024 Feb 22; 38(2):388-393. PubMed ID: 38129208 [Abstract] [Full Text] [Related]
47. Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery. Omar HR, Enten G, Karlnoski R, Ching YH, Mangar D, Camporesi EM. Drugs R D; 2015 Jun 22; 15(2):187-94. PubMed ID: 25862216 [Abstract] [Full Text] [Related]
48. Recombinant-activated factor VII in the paediatric cardiac surgery: single unit experience. Agarwal V, Okonta KE, Lal PS. Afr J Paediatr Surg; 2012 Jun 22; 9(3):193-7. PubMed ID: 23250238 [Abstract] [Full Text] [Related]
49. Activated Factor 7 Versus 4-Factor Prothrombin Complex Concentrate for Critical Bleeding Post-Cardiac Surgery. Mehringer SL, Klick Z, Bain J, McNeely EB, Subramanian S, Pass LJ, Drinkwater D, Reddy VS. Ann Pharmacother; 2018 Jun 22; 52(6):533-537. PubMed ID: 29332420 [Abstract] [Full Text] [Related]
50. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery. Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D. J Vasc Surg; 2011 Apr 22; 53(4):1032-7. PubMed ID: 21215579 [Abstract] [Full Text] [Related]
53. Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients. AlGahtani FH, Alshaikh M, AlDiab A. Ann Saudi Med; 2010 Apr 22; 30(3):198-202. PubMed ID: 20427935 [Abstract] [Full Text] [Related]
54. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery]. Gong ZY, Gao CQ, Xiao CS, Li BJ, Ma XH, Zhang CM. Zhonghua Wai Ke Za Zhi; 2008 Oct 01; 46(19):1497-501. PubMed ID: 19094631 [Abstract] [Full Text] [Related]
57. Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland. Donovan PJ, Iedema J, McLeod DS, Kubler P, Pillans P. ANZ J Surg; 2013 Mar 01; 83(3):149-54. PubMed ID: 23137066 [Abstract] [Full Text] [Related]